afp
bleomycin
bronchogenic
cap
chance
cisplatin
cooperative
crs
cyclophosphamide
doxorubicin
eastern
ecog
efficacious
entered
est
evaluable
fluorouracil
institution
lethal
mitomycin
modest
nscbc
october
oncology
prs
regimens
shrinkage
threatening
vinblastine
|